Well different situations . UNCY is a binary event ....clinical trial results due any day now . RZLT ...when stocks go parabolic they can be subject to aggressive profit taking . What is driving the PPS increase in RZLT ? Two hedge funds control 66 % of the stock and insiders control 20% I think ...so if 86% of the stock holders refuse to sell ...are they in effect creating a type of short squeeze. ?
The obvious speculation ( to me at least ) is that Big Pharma is interested in RZ402 ...their DME drug . To have an oral medication that can delay the need for eye injections for diabetics ( I think roughly 80% of diabetics eventually develop DME...altho would need to chk ) My wild guess is that if the interest is there ...RZLT could probably sell the rights to RZ402 for around $100m . BP would spend at least another $100m getting it thru the trials and eventually approved ....but then for a cost of $200m plus you have a drug that could be used by millions of diabetics worldwide.
I was buying RZLT back in Feb for around $1.60 ...largely because Vivo and Nantahala were backing them and I think some on their scientific advisory board are widely respected . Its done far better than I expected . Congrats on your trade Kiwi
News 
Market Data 
Discover 
